[Acromegaly in the elderly]
- PMID: 19539897
- DOI: 10.1016/j.ando.2009.05.002
[Acromegaly in the elderly]
Abstract
Multicentric registers such as The French Acromegaly Register provide data on rare disorders that are otherwise difficult to obtain, so avoiding extrapolation from limited data sets. This study focuses on clinical, hormonal and therapy characteristics of acromegaly in people over 70 years old. The objective was to compare this population with the youngest to disclose if the medical management was similar.
Patients and methods: The data were obtained from the 30 centres that have registered patients in the Acromegaly Register since 1999.
Results: The register listed 644 acromegaly patients on 1st January 2005, of whom 68 (22 men and 46 women) were over 70 years old, independently of the diagnosis date of their disease. Their average age was 76.8 + or - 5 years (range: 70-95) and they had suffered from acromegaly for 11 + or - 6 years (compared to 7 years in those aged less than 70). Their BMI were similar. Diabetes and hypertension were more frequent than in younger acromegalic patients and in the general French population matched for age. Circulating GH and IGF-1 concentrations were lower than in the younger acromegalic patients on inclusion and 1 year after treatment. There was no significant difference in the tumor size. Only 44% of the patients over 70 underwent surgery, against 90% of patients under 70 years. However, the fractions of young and elderly patients with a controlled disease 1 year after inclusion were the same (51%).
Conclusion: In the limits of the use of register, these data reveal a high prevalence of diabetes and hypertension in the eldest acromegalic patients. Despite much less frequent surgical intervention, patients' disease under control is equivalent to the younger population 1 year after the initial interview, confirming the effectiveness of the choices of treatment.
Similar articles
-
[Hypertension and acromegaly in the elderly: French Registry Data].Arch Mal Coeur Vaiss. 2007 Aug;100(8):660-3. Arch Mal Coeur Vaiss. 2007. PMID: 17928771 French.
-
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.Eur J Endocrinol. 2011 Jun;164(6):877-84. doi: 10.1530/EJE-10-1050. Epub 2011 Apr 4. Eur J Endocrinol. 2011. PMID: 21464140
-
The influence of age on the GH-IGF1 axis in patients with acromegaly.Eur J Endocrinol. 2008 Oct;159(4):375-9. doi: 10.1530/EJE-08-0243. Epub 2008 Jul 24. Eur J Endocrinol. 2008. PMID: 18653547
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
-
Hormonal diagnosis of GH hypersecretory states.J Endocrinol Invest. 2003;26(10 Suppl):27-35. J Endocrinol Invest. 2003. PMID: 15497657 Review.
Cited by
-
Hypertension in Acromegaly in Relationship to Biochemical Control and Mortality: Global ACROSTUDY Outcomes.Front Endocrinol (Lausanne). 2020 Nov 30;11:577173. doi: 10.3389/fendo.2020.577173. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33329385 Free PMC article.
-
Acromegaly in the elderly patient.Arch Endocrinol Metab. 2019 Nov-Dec;63(6):638-645. doi: 10.20945/2359-3997000000194. Arch Endocrinol Metab. 2019. PMID: 31939489 Free PMC article. Review.
-
Craniofacial impact of acromegaly: when muscle ma-sse-tter.Pituitary. 2024 Oct;27(5):437-439. doi: 10.1007/s11102-024-01436-6. Epub 2024 Jul 26. Pituitary. 2024. PMID: 39060818 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous